Zydus and Lupin join hands to Co-market treatment

Zydus Lifesciences Limited and Lupin Limited have entered a licensing and supply agreement to co-market Saroglitazar Mg, designed for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steato Hepatitis (NASH) in India. Saroglitazar Mg offers enhanced compliance with its once daily 4mg dose, reducing pill burden and providing patients with greater convenience.


Under the agreement, Lupin gains semi-exclusive rights to co-market the product in India under the brand name LINVAS. Zydus will continue marketing the drug under the brand names Lipaglyn and Bilypsa. Lupin will make upfront licensing fees and milestone payments to Zydus based on predefined achievements.


In India, NAFLD is not confined to obese or Diabetes Mellitus patients; it can also develop independently of obesity, termed "lean" NAFLD. The prevalence of NAFLD/NASH has risen due to increased obesity and other lifestyle-related conditions.


Dr. Sharvil Patel, Managing Director of Zydus Lifesciences Ltd., noted that Saroglitazar Mg has substantially improved patients' quality of life. Nilesh Gupta, Managing Director of Lupin, expressed excitement about the partnership, stating it reinforces their commitment to meeting patients' unmet needs in India and enhancing their gastroenterology portfolio.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Candlestick Patterns

blog-logo

11 mins read . 03 Oct 2024

Ascending Triangle Pattern - Definition, Tips, Component & How to Trade

  • 0 people read
blog-logo

IPO

blog-logo

5 mins read . 19 Sep 2024

Vision Infra Equipment Solutions Limited IPO

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions